Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ : revenue, balance sheet and financial ratios

CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ is a French company founded 4 years ago, specialized in the sector Location de terrains et d'autres biens immobiliers. Based in THEZAN-LES-BEZIERS (34490), this company of category PME shows in 2024 a revenue of 32 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ (SIREN 911260438)
Indicator 2024
Revenue 31 970 €
Net income 270 €
EBITDA 808 €
Net margin 0.8%

Revenue and income statement

In 2024, CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ achieves revenue of 32 k€. After deducting consumption (558 €), gross margin stands at 31 k€, i.e. a rate of 98%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 808 €, representing 2.5% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 270 €, i.e. 0.8% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

31 970 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

31 412 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

808 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

462 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

270 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

2.5%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Cash flow represents 1.9% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

0.0%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

1.927%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

73.5%

Solvency indicators evolution
CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ

Sector positioning

Debt ratio
0.0 2024
2024
Q1: -20.62
Med: 5.98
Q3: 146.83
Good

In 2024, the debt ratio of CENTRE DE MEDECINES DOUCE... (0.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
0.0% 2024
2024
Q1: 0.04%
Med: 27.47%
Q3: 73.82%
Average

In 2024, the financial autonomy of CENTRE DE MEDECINES DOUCE... (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
0.0 years 2024
2024
Q1: -0.02 years
Med: 0.65 years
Q3: 10.57 years
Good

In 2024, the repayment capacity of CENTRE DE MEDECINES DOUCE... (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 98.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

98.887

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.124

Liquidity indicators evolution
CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ

Sector positioning

Liquidity ratio
98.89 2024
2024
Q1: 83.33
Med: 307.99
Q3: 1318.25
Average

In 2024, the liquidity ratio of CENTRE DE MEDECINES DOUCE... (98.89) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.12x 2024
2024
Q1: 0.0x
Med: 0.0x
Q3: 20.04x
Good

In 2024, the interest coverage of CENTRE DE MEDECINES DOUCE... (0.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 14 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 18 days. Favorable situation: supplier credit is longer than customer credit by 4 days. WCR is negative (-2 days): operations structurally generate cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-134 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

14 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

18 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-2 j

WCR and payment terms evolution
CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ

Positioning of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ in its sector

Comparison with sector Location de terrains et d'autres biens immobiliers

Valuation estimate

Based on 169 transactions of similar company sales in 2024, the value of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ is estimated at 10 366 € (range 3 665€ - 19 132€). With an EBITDA of 808€, the sector multiple of 5.6x is applied. The price/revenue ratio is 0.81x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
169 transactions
3k€ 10k€ 19k€
10 366 € Range: 3 665€ - 19 132€
NAF 5 année 2024

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
808 € × 5.6x
Estimation 4 525 €
1 198€ - 8 076€
Revenue Multiple 30%
31 970 € × 0.81x
Estimation 25 788 €
9 854€ - 48 088€
Net Income Multiple 20%
270 € × 6.8x
Estimation 1 840 €
553€ - 3 338€
How is this estimate calculated?

This estimate is based on the analysis of 169 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Location de terrains et d'autres biens immobiliers)

Compare CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ with other companies in the same sector:

Voir toutes les statistiques du secteur Location de terrains et d'autres biens immobiliers

Frequently asked questions about CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ

What is the revenue of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ ?

The revenue of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ in 2024 is 32 k€.

Is CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ profitable?

Yes, CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ generated a net profit of 270€ in 2024.

Where is the headquarters of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ ?

The headquarters of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ is located in THEZAN-LES-BEZIERS (34490), in the department Herault.

Where to find the tax return of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ ?

The tax return of CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ operate?

CENTRE DE MEDECINES DOUCES SASU JUSIANE FARENQ operates in the sector Location de terrains et d'autres biens immobiliers (NAF code 68.20B). See the 'Sector positioning' section above to compare the company with its competitors.